Dave Dipak, Bhattacharjee Sujoy K, Shah Dilip D, Mascerhans Amrithlal, Dey Paresh C, Arumugan Subramanian, Mehra Vikas, Agarwal Vinod, Garg Sandeep, Gore Satish Chandra, Choudhry Rajiv Raj, Mahajan Manish, Bharat Suyash
Orthopedics, Healthcare Global (HCG) Hospital, Ahmedabad, IND.
Orthopedics, Sarvodaya Hospital and Research Centre, Faridabad, IND.
Cureus. 2022 Jul 26;14(7):e27275. doi: 10.7759/cureus.27275. eCollection 2022 Jul.
Background This is an observational study conducted to determine the prevalence of osteoporosis and osteopenia in patients undergoing elective arthroplasty and spinal procedures in India. Methods This observational, multicentre study included both male and female patients. Their bone mineral density and fracture risk were measured using dual-energy x-ray absorptiometry (DEXA) and Fracture Risk Assessment Tool (FRAX: Centre for Metabolic Bone Diseases, University of Sheffield, UK), respectively, in compliance with the guidelines for Good Epidemiological Practice (ISRCTN: 14543098). Results The study revealed that majority (76.4%; 97/127) of the patients had low BMD; over one-third had osteoporosis (39.4%; 50/127) or osteopenia (37%; 47/127). Among those undergoing total knee replacement (TKR)/total hip replacement (THR), majority (75.6%; 59/78) had low BMD (osteoporosis: 38.5% {30/78}; osteopenia: 37.2% {29/78}). Among the patients undergoing spinal procedures, all except two (93.10%; 27/29) had low BMD, two-thirds had osteoporosis (65.5%; 19/29), and around one-fourth had osteopenia (27.6%; 8/29). Radial BMD measurements showed higher prevalence of osteoporosis and osteopenia. Based on FRAX score, nearly 30% of patients were at a high risk of hip fracture in the next 10 years. As per National Osteoporosis Foundation (NOF) guidelines, most (59.79%; 58/97) patients with osteoporosis/osteopenia met criteria for pharmacological treatment. Conclusions Regular preoperative bone health evaluation should be adopted and osteoporosis/osteopenia patients should be adequately managed pharmacologically in India.
背景 这是一项观察性研究,旨在确定印度接受择期关节置换术和脊柱手术患者中骨质疏松症和骨质减少症的患病率。方法 这项观察性多中心研究纳入了男性和女性患者。分别使用双能X线吸收法(DEXA)和骨折风险评估工具(FRAX:英国谢菲尔德大学代谢性骨病中心),按照良好流行病学实践指南(ISRCTN:14543098)测量他们的骨矿物质密度和骨折风险。结果 研究显示,大多数患者(76.4%;97/127)骨密度较低;超过三分之一的患者患有骨质疏松症(39.4%;50/127)或骨质减少症(37%;47/127)。在接受全膝关节置换术(TKR)/全髋关节置换术(THR)的患者中,大多数(75.6%;59/78)骨密度较低(骨质疏松症:38.5%{30/78};骨质减少症:37.2%{29/78})。在接受脊柱手术的患者中,除两名患者外(93.10%;27/29)均骨密度较低,三分之二的患者患有骨质疏松症(65.5%;19/29),约四分之一的患者患有骨质减少症(27.6%;8/29)。桡骨骨密度测量显示骨质疏松症和骨质减少症的患病率较高。根据FRAX评分,近30%的患者在未来10年内有髋部骨折的高风险。根据美国国家骨质疏松基金会(NOF)指南,大多数(59.79%;58/97)骨质疏松症/骨质减少症患者符合药物治疗标准。结论 在印度应采用常规术前骨健康评估,骨质疏松症/骨质减少症患者应进行充分的药物治疗。